Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT02362646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 159 participants
- Registry
-
NCT02362646
-
- Other papers using this trial's data
- Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02362646. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-08-10 (actual). Results posted on 2019-11-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
- Condition
- Heart Failure
- Condition
- Cardiomyopathy
- Condition
- Ventricular Dysfunction
- Intervention (Biological)
- MPC Intramyocardial Injection
- Intervention (Drug)
- Control Solution
- Lead sponsor
- Annetine Gelijns
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02362646- Content hash
c56359fbccf7b67eab471deb1c0ace86b832bf7a89113bd8b893f71b3dbf3133